NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE112230 Query DataSets for GSE112230
Status Public on Jun 21, 2018
Title LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade
Organisms Homo sapiens; Mus musculus
Experiment type Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Summary Chromatin regulators play a broad role in regulating gene expression, and when gone awry, can lead to cancer. Here we demonstrate that ablation of the histone demethylase LSD1 in cancer cells increases repetitive element expression, including ERVs, and decreases expression of RNA-induced silencing complex (RISC) components. Significantly, this leads to dsRNA stress and activation of type 1 interferon, which stimulates anti-tumor T cell immunity and restrains tumor growth. Furthermore, LSD1 depletion enhances tumor immunogenicity and T cell infiltration in poorly immunogenic tumors, and elicits significant responses of checkpoint blockade-refractory mouse melanoma to anti-PD-1 therapy. Consistently, TCGA data analysis shows an inverse correlation between LSD1 expression and CD8+ T cell infiltration in various human cancers. Our study identifies LSD1 as a potent inhibitor of anti-tumor immunity and responsiveness to immunotherapy, and suggests LSD1 inhibition combined with PD-(L)1 blockade as a novel cancer treatment strategy.
 
Overall design Gene expression profiling of in vitro control and LSD1 KD MCF-7 cells (in biological replicates), as well as ex vivo scramble, LSD1 KO and LSD1/MDA5 DKO B16 tumor cells (in biological triplicates) was analyzed by RNA-seq. Genomic occupancy of LSD1, H3K4me1 and H3K4me2 in in vitro control and LSD1 KD MCF-7 cells, as well as ex vivo scramble and LSD1 KO B16 tumor cells was analyzed by ChIP-seq.
 
Contributor(s) Shi Y, Sheng W, Chen S, He HH
Citation(s) 29937226
Submission date Mar 22, 2018
Last update date Mar 27, 2019
Contact name Wanqiang Sheng
E-mail(s) nussheng@gmail.com
Organization name Zhejiang University School of Medicine
Department Department of Immunology
Lab The Sheng Lab
Street address 866 Yuhangtang Road
City Hangzhou
State/province Zhejiang
ZIP/Postal code 310058
Country China
 
Platforms (3)
GPL16791 Illumina HiSeq 2500 (Homo sapiens)
GPL17021 Illumina HiSeq 2500 (Mus musculus)
GPL19057 Illumina NextSeq 500 (Mus musculus)
Samples (29)
GSM3061379 sh-Ctrl_Input
GSM3061380 sh-Ctrl_LSD1
GSM3061381 sh-Ctrl_H3K4me1
Relations
BioProject PRJNA445303
SRA SRP136272

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE112230_2018-03-01_rnaseq_mm_counts.csv.gz 379.7 Kb (ftp)(http) CSV
GSE112230_2018-03-14_rnaseq_hs_counts.csv.gz 441.9 Kb (ftp)(http) CSV
GSE112230_2018-03-22_repeat_count_hs.csv.gz 21.0 Kb (ftp)(http) CSV
GSE112230_2018-03-22_repeat_count_mm.csv.gz 31.6 Kb (ftp)(http) CSV
GSE112230_RAW.tar 2.3 Gb (http)(custom) TAR (of BW, NARROWPEAK)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap